September 23, 2015 - Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines with recommendations to improve cardiovascular health.
Search for "" returned 68 matches
2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal Implantable Cardioverter-Defibrillator Programming and Testing24544
November 19, 2015 - The benefits and risks of ICD therapy for patients are directly impacted by the programming and surgical decisions made by the clinician. This expert consensus statement systemically describes four important clinical issues and addresses programming of: bradycardia mode and rate, tachycardia detection, tachycardia therapy, and intraprocedural testing of defibrillation efficacy.
May 15, 2008 — The Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary document updates the previous version published in 2002.
2005 The Relation between Patients' Outcomes and the Volume of Cardioverter-Defibrillator Implantation Procedures Performed by Physicians Treating M...1376
December 13, 2005 — This is the first study designed to look at the relation between patient outcomes and physicians'/hospitals' volume of cardioverter-defibrillator implantation to determine whether implantation should be limited to physicians with high procedural volume.
Pacemakers are devices that are implanted into the body, just below the collarbone, to take over the job of the heart’s own electrical system and prevent slow heart rates. Although they weigh only an ounce and are the size of a large wristwatch face, a pacemaker contains a computer with memory and electrical circuits, a powerful battery (generator), and special wires called “leads.” The generator creates electrical impulses that are carried by the leads to the heart muscle, signaling it to pump.
Defibrillation, or shock, can be the only way to stop certain heart arrhythmias, or irregular heartbeats, before they kill. If the heart beats too quickly, the chambers, or ventricles, will not have enough time to fill with blood and pump blood to the rest of the body, which can cause death. For people at high risk for the deadliest forms of arrhythmias – called ventricular tachycardia and ventricular fibrillation – an internal “shocking” device may be the best protection against sudden cardiac arrest (SCA).
2011 Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers, and Arrhythmia Monitors1308
July 2011—Developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA) and the Society of Thoracic Surgeons (STS), a diverse panel of experts in pacemaker and defibrillator management focused on medical procedures that might interfere with cardiovascular implantable electronic devices (CIEDs) function.
|This document was reaffirmed on March 7, 2018, and will be formally assessed by March 2021.|
2010 HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in Patients Nearing End of Life or R...20183
May 17, 2010—This document was developed in collaboration with and endorsed by the American College of Cardiology (ACC), the American Geriatrics Society (AGS), the American Academy of Hospice and Palliative Medicine (AAHPM), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), and the Hospice and Palliative Nurses Association (HPNA). It focuses on patients nearing the end of life and addresses patients who have made a decision for CIED deactivation at other times, as well as the rights and responsibilities of clinicians (and others, such as industry-employed allied professionals) who may not wish to perform deactivation.
|This document was reaffirmed on March 7, 2018, and will be formally assessed by March 2023.|